| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $7.3M | -4.9% |
| SG&A Expense | $8.1M | -7.3% |
| Operating Income | -$15.4M | +6.2% |
| Income Tax | $2K | -30.6% |
| Net Income | -$15.0M | +2.6% |
| EPS (Basic) | -$1.61 | +12.0% |
| EPS (Diluted) | -$1.61 | +12.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.8M | -56.7% |
| Current Assets | $6.6M | -52.7% |
| Total Assets | $7.3M | -50.8% |
| Current Liabilities | $3.4M | +22.3% |
| Total Liabilities | $3.4M | +19.2% |
| Stockholders' Equity | $3.9M | -67.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.3M | +8.1% |
| Investing Cash Flow | $17.1M | +0.0% |
| Financing Cash Flow | $4.7M | — |